Charles River Laboratories (CRL) Tops Q1 EPS by 25c; raises guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $280.05 -0.43%
Financial Fact:
Continuing operations (in dollars per share): 0.78
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Continuing operations (in dollars per share): 0.78
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.34, $0.25 better than the analyst estimate of $2.09. Revenue for the quarter came in at $984.2 million versus the consensus estimate of $941.47 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $9.30-$9.80, versus the consensus of $9.31.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
